Search

everythinglearnresearchcommunity

for

Search:↓

Permanent hair loss after a stem cell transplant can be a sign of chronic immune system attack on the scalp.

People with allergies or high eosinophil levels have a higher chance of severe hair loss from alopecia areata, and sudden hair loss can indicate chronic graft-versus-host disease.

Hair follicles are key to treating vitiligo and alopecia areata, but challenges exist.

Regenerative medicine is effective and safe for treating vitiligo.

Folliculotropic mycosis fungoides has a worse prognosis than other types, with survival rates varying significantly based on subtype and organ involvement.

Some patients developed hair loss after islet cell transplant possibly due to their immune-suppressing medications.

Different types of stem cells exist within individual skin layers, and they can adapt to damage, transplantation, or tumor growth. These cells are regulated by their environment and genetic factors. Tumor growth is driven by expanding, genetically altered cells, not long-lived mutant stem cells. There's evidence of cancer stem cells in skin tumors. Other cells, bacteria, and genetic factors help maintain balance and contribute to disease progression. A method for growing mini organs from single cells has been developed.

Iron deficiency is common in kidney transplant patients, and while iron treatment helps, it can cause high red blood cell levels.

The secretome from mesenchymal stem cells is a promising treatment that may repair tissue and avoid side effects of stem cell transplantation.

Mesenchymal stem cell therapy shows promise for liver disease but faces challenges in standardization and approval.

Hair follicle stem cells can generate all hair cell types, skin, and sebaceous glands.

Freezing and storing special stem cells from hair follicles keeps their ability to grow hair and turn into different cell types.

Layer-by-Layer self-assembly is promising for biomedical uses like tissue engineering and cell therapy, but challenges remain in material safety and process optimization.

Microencapsulation helps protect and track therapeutic cells, showing promise for treating various diseases, but more work is needed to improve the technology.

Busulfan/cyclophosphamide and total bone irradiation are equally effective for AML transplants.

The best method for transplanting skin cells to regenerate hair follicles is the Hemi-vascularized sandwich method, as it produces more mature follicles and promotes hair growth.

Targeting and modifying the stem cell niche can improve regenerative therapies.

Thymus transplantation successfully restored immune function in infants with FOXN1 deficiency.

Researchers created a fully functional, bioengineered skin system with hair from stem cells that successfully integrated when transplanted into mice.

Myoblast transplantation shows promise for treating various muscle and heart conditions.

Hair regrowth in alopecia universalis may be possible by altering immune cells.

Stem cells in hair follicles can become various cell types, including neurons.

Platelet-rich plasma may improve healing and hair growth in hair transplant surgery.

Embryonic and adult stem cells are valuable for improving skin grafts and cell therapy.

Direct hair implantation with special pens improves hair transplant precision and effectiveness.

EPI-NCSCs from hair follicles may help treat brain development issues in mice.

Improved wigs showed good compatibility and no adverse reactions after transplantation.

Improving mesenchymal stromal cell therapies requires overcoming cell death and optimizing delivery methods.

Neural organoids show promise for future CNS disease treatments.

Guinea pig fat stem cells can become hair cell-like cells in a lab.